Lafora progressive myoclonus epilepsy: disease course homogeneity in a genetic isolate

J Child Neurol. 2008 Feb;23(2):240-2. doi: 10.1177/0883073807309245.

Abstract

Lafora epilepsy is characterized by starch formation in brain and skin and is diagnosed by skin biopsy or mutation detection. It has variable ages of onset (6-19 years) and death (18-32 years) even with the same mutation, likely due to extramutational factors. The authors identified 14 Lafora epilepsy patients in the genetic isolate of tribal Oman. The authors show that in this homogeneous environment and gene pool, the same mutation, EPM2B-c.468-469delAG, results in highly uniform ages of onset (14 years) and death (21 years). Biopsy, on the other hand, was not homogeneous (positive in 4/5 patients) and is, therefore, less sensitive than mutation testing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Carrier Proteins / genetics*
  • Carrier Proteins / metabolism
  • Consanguinity
  • DNA Mutational Analysis
  • Death
  • Humans
  • Lafora Disease / ethnology
  • Lafora Disease / genetics*
  • Lafora Disease / mortality
  • Lafora Disease / physiopathology
  • Oman
  • Population Groups / genetics*
  • Skin / metabolism
  • Ubiquitin-Protein Ligases

Substances

  • Carrier Proteins
  • NHLRC1 protein, human
  • Ubiquitin-Protein Ligases